Mkts

Sunshine Biopharma Inc.

NASDAQ: SBFM
$2.71-0.08 (-2.87%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
2.682.85
52-week range
2.53464.00
Today
Open2.73
Previous close2.71
Volume—
Valuation
Market cap2.06M
P/E ratio—
EPS (TTM)-10.03
Income & risk
Dividend / yield—
Beta-8.43
Avg volume221.5K
Discussion

SBFM News

Stories mentioning SBFM from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue8,0898,5789,4179,4108,9019,5958,4359,303
Cost of Goods Sold5,9085,5486,3445,9876,1716,5015,5696,947
Gross Profit2,1813,0293,0743,4232,7303,0942,8662,356
Operating Expenses
Research & Development32.0074.00119.00196.00215.00150.00126.00436.00
Sales General & Admin
Total Operating Expenses
Operating Income (Loss)(1,396)(1,789)(1,087)(2,055)(1,296)(2,087)(1,106)(1,268)
Interest Income
Interest Expense
Other Expense
Pretax Income(1,244)(1,733)(1,021)(1,980)(1,220)(2,287)(983.00)(838.00)
Tax Provision0.00408.00(137.00)(209.00)(40.00)(128.00)215.00(344.00)
Net Income (Loss)(1,244)(2,140)(884.00)(1,771)(1,180)(2,158)(1,198)(494.00)
Earnings Per Share (Basic)(0.25)(0.51)(0.19)(0.39)(0.44)(3.07)(0.94)(9.94)
Earnings Per Share (Diluted)(0.82)(0.44)(3.07)(43.48)
Weighted Average Shares Outstanding (Basic)4,9064,1574,5564,4962,703702.001,26850.00
Weighted Average Shares Outstanding (Diluted)3,6052,703702.001,26841.00

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About SBFM

Sunshine Biopharma Inc. (NASDAQ: SBFM) is a stock listed on the Nasdaq Stock Market under the ticker symbol SBFM. It last traded at $2.71 (Nov 6, 2026, 4:00 PM ET), down 2.9% on the day. That gives Sunshine Biopharma a market capitalisation of $2.1M.

Over the past 52 weeks SBFM has traded between $2.53 and $464.00.

Revenue for the quarter ended Mar 31, 2026 was $8.1M; a net loss of $1.2M. Revenue was down 9.1% from $8.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$8.1M-$1.2M-15.4%
Dec 31, 2025$8.6M-$2.1M-24.9%
Sep 30, 2025$9.4M-$884.0K-9.4%
Jun 30, 2025$9.4M-$1.8M-18.8%

From Sunshine Biopharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…